Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm

Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03641326	Sunitinib in Sarcomas of the Central Nervous System	terminated	Phase 2	5	National Cancer Institute (NCI)NIH	1	Apr 19, 2022	clinicaltrials

Data updated 22 days agoSource updated Apr 19, 2022source: clinicaltrials